Cohance Life gets USFDA Form 483 with four observations
Cohance Lifescience said it received a Form FDA 483 with four observations following an inspection at its Telangana FDF plant, as disclosed in an exchange filing issued Saturday, September 5.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.